Plasmodium falciparum cellular components (P. falciparum)

Plasmodium falciparum is a unicellular protozoan parasite and the primary causative agent of the most severe form of malaria in humans [9, 10]. The term "cellular components" in a pharmacological context refers to the collective metabolic and structural machinery of the parasite, which serves as the target for phenotypic drug discovery and whole-organism assays [1, 4]. Key therapeutic targets within these components include the food vacuole, where the parasite detoxifies heme from host hemoglobin; the apicoplast, a unique organelle essential for isoprenoid and fatty acid synthesis; and the mitochondrial electron transport chain [1, 2, 18]. Antimalarial drugs such as chloroquine and artemisinins act by disrupting these vital processes, leading to the accumulation of toxic metabolic byproducts or oxidative damage that kills the parasite [2, 8]. However, the clinical utility of many drugs is increasingly threatened by the emergence of multi-drug resistance, mediated by mutations in parasite transporters and proteins like PfCRT and Kelch13 [8, 13]. Understanding the diverse cellular components of P. falciparum remains critical for developing next-generation therapies to combat resistant strains [12, 18].

Other names

P. falciparumMalarial parasitePlasmodium falciparum parasiteFalciparum malaria

Inhibition of heme biocrystallization, induction of oxidative stress, inhibition of dihydrofolate reductase, and inhibition of mitochondrial electron transport.